http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007031363-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2e61866e714198ee02a24037c9670828
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-335
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D313-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-54
filingDate 2005-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec6154380bc955fd3ed78776e7e3bb86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f90fdf38f7b0c60e8131a23853ed70d0
publicationDate 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2007031363-A
titleOfInvention Method for producing dibenz [b, e] oxepin derivative and intermediate thereof
abstract Provided is a method for industrially producing a dibenz [b, e] oxepin derivative useful as an antiallergic agent by using a commercially available compound as a starting material, and also provides a novel intermediate for its production. . The present invention provides a method for obtaining a dibenz [b, e] oxepin derivative (VII) by subjecting compound (I) to the reaction of the following four steps, and also provides compound (III) obtained by the first step as a novel intermediate. Provide as a body. [Chemical 1] (In the formula, X and Y represent a halogen atom, and R represents a lower alkyl group.) [Selection figure] None.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009114166-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105693685-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008099900-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102757339-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105693685-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011033532-A1
priorityDate 2005-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426087103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20373272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7895
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87405687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415724632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415787057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426391464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451429851
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14367694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466658495
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407532334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5463289
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6451477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226678769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450520921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394734
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535285

Total number of triples: 47.